alexa Inhibition Of Protein Tyrosine Phosphatase-1B In Vitro And In Vivo | 63543
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Joint Event on 15th World Congress on Biotechnology And Biotech Industries Meet and 2nd International Conference on Enzymology and Molecular Biology

Marvin W Makinen
The University of Chicago, USA
Keynote: J Biotechnol Biomater
DOI: 10.4172/2155-952X.C1.069
Abstract
A large number of studies on protein tyrosine phosphatases (PTPases) have been directed towards drug design for therapeutic intervention because of their critical roles in homeostasis and disorders of metabolism. In contrast to protein tyrosine kinases, virtually all inhibitors tested against PTPases exhibit only competitive behavior because of their consensus, active site sequence H/V-C-X 5-R-S/T, a condition leading to low specificity. Having identified protein tyrosine phosphatase- 1B (PTP1B) as the target enzyme of the vanadyl (VO2+) chelate bis(acetylacetonato)oxidovanadium(IV) [VO(acac)2] in cultured 3T3-L1 adipocytes, we have investigated the basis of inhibition by the VO2+-chelate through steady-state, kinetic investigations of the recombinant human enzyme (residues 1-321). Our results differ from investigations by others because we compared the influence of the chelate in the presence of the synthetic substrate p-Nitrophenylphosphate (pNPP) and the phosphotyrosine-containing undecapeptide DADEpYLIPQQG mimicking residues 988-998 of the epidermal growth factor receptor, a physiologically relevant substrate. We also compared the inhibitory behavior of VO(acac)2 to that of two other VO2+-chelates similarly known for their capacity to enhance cellular uptake of glucose as insulin mimetics. The results indicate that VO (acac)2 acts as a classical uncompetitive inhibitor in the presence of DADEpYLIPQQG but exhibits only apparent competitive inhibition with pNPP as substrate because uncompetitive inhibitors are more potent pharmacologically than competitive inhibitors, structural characterization of the site of uncompetitive binding of VO(acac)2 to PTP1B may provide a new approach to design of inhibitors of high specificity for therapeutic purposes.
Biography

Marvin W. Makinen is Professor in the Department of Biochemistry and Molecular Biology in The University of Chicago, USA and has served as chairman of the department from 1988 to 1993. He is also a founding member of the Human Rights Board at the university. He did his D.Phil., in the year 1976 in Molecular Biophysics at Oxford University, U.K. Over the past 40 years at The University of Chicago, research in the Makinen lab has been directed towards the structural basis of action of metalloenzymes and the application of magnetic resonance methods to characterize active site structure and stereochemical relationships of substrates to active site residues in true reaction intermediates. More recent studies have been carried out to identify the target enzymes of metal -chelates that enhance the cellular uptake of glucose. Because some metal-chelates are associated with the capacity to enhance preferential uptake of glucose into xenograft tumors in small laboratory animal models, present research has been directed towards testing their potential as pharmacologic reagents to increase sensitivity of detection of malignant lesions by PET imaging.

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version